Fiera Capital (Canada)
GSK icon

Fiera Capital (Canada)’s GSK GSK Stock Holding History

Fiera Capital (Canada)’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-18,408
Closed -$992K – 779
2016
Q3 		$992K Sell
18,408
-100,440
-85% -$5.51M 0.01% 534
2016
Q2 		$6.44M Sell
118,848
-24,160
-17% -$1.27M 0.04% 283
2016
Q1 		$7.25M Buy
143,008
+3,280
+2% +$163K 0.05% 138
2015
Q4 		$7.05M Sell
139,728
-23,040
-14% -$1.17M 0.05% 159
2015
Q3 		$7.82M Buy
162,768
+135,700
+501% +$7.06M 0.07% 150
2015
Q2 		$1.41K Buy
27,068
+288
+1% +$16.2K 0.01% 373
2015
Q1 		$1.54M Buy
26,780
+3,708
+16% +$213K 0.01% 361
2014
Q4 		$1.23M Sell
23,072
-79,508
-78% -$4.45M 0.01% 382
2014
Q3 		$5.89M Sell
102,580
-31,532
-24% -$1.93M 0.04% 194
2014
Q2 		$8.96M Sell
134,112
-5,076
-4% -$344K 0.05% 183
2014
Q1 		$9.3M Sell
139,188
-19,804
-12% -$1.34M 0.07% 171
2013
Q4 		$10.6M Buy
158,992
+107,632
+210% +$6.98M 0.09% 162
2013
Q3 		$3.22M Buy
51,360
+480
+0.9% +$30.9K 0.03% 175
2013
Q2 		$3.18M Buy
+50,880
New +$3.23M 0.03% 162

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fiera Capital (Canada)'s GSK Position: Q4 2016 in Review

Fiera Capital (Canada) sold out of GSK (GSK) in Q4 2016, closing a stake of 18,408 shares — an estimated $992K sold.

Fiera Capital (Canada) first reported a position in GSK in Q2 2013 and held it in 14 quarters. The position peaked at $10.6M in Q4 2013. 762 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

  • Fiera Capital (Canada) reported no remaining GSK position as of Q4 2016 after selling out during the quarter.
  • Fiera Capital (Canada) sold 18,408 GSK shares in Q4 2016, an estimated $992K.
  • Fiera Capital (Canada) first reported a position in GSK in Q2 2013 and held it in 14 quarters.
  • Fiera Capital (Canada)'s GSK position peaked at $10.6M in Q4 2013.
  • 762 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on Fiera Capital (Canada)'s 13F filing for Q4 2016, filed 14 Feb 2017.